Medtronic annual total liabilities
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Medtronic Total Liabilities Growth & History (MDT)
Medtronic's total liabilities was $42.96B for fiscal 2026.
View full Medtronic company overviewMedtronic annual total liabilities history
| Fiscal year | Period ended | Total liabilities | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-04-24 | $42.96B | −$468.0M | −1.08% |
| 2025 | 2025-04-25 | $43.42B | $3.86B | +9.76% |
| 2024 | 2024-04-26 | $39.56B | $278.0M | +0.71% |
| 2023 | 2023-04-28 | $39.28B | $1.02B | +2.67% |
| 2022 | 2022-04-29 | $38.26B | −$3.22B | −7.77% |
| 2021 | 2021-04-30 | $41.48B | $1.66B | +4.18% |
| 2020 | 2020-04-24 | $39.82B | $335.0M | +0.85% |
| 2019 | 2019-04-26 | $39.48B | −$1.09B | −2.68% |
| 2018 | 2018-04-27 | $40.57B | −$8.96B | −18.08% |
| 2017 | 2017-04-28 | $49.53B | $1.95B | +4.09% |
| 2016 | 2016-04-29 | $47.58B | −$5.87B | −10.99% |
| 2015 | 2015-04-24 | $53.45B | $34.95B | +188.95% |
| 2014 | 2014-04-25 | $18.50B | — | — |
Medtronic quarterly total liabilities
Q4.14
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
Q3.26
Q4.26
Q1.27
| Fiscal quarter | Period ended | Total liabilities | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-07-31 | $42.46B | −$383.0M | −0.89% |
| Q4 2026 | 2026-04-24 | $42.96B | −$468.0M | −1.08% |
| Q3 2026 | 2026-01-31 | $42.29B | $1.93B | +4.78% |
| Q3 2026 | 2026-01-23 | $42.29B | $1.93B | +4.78% |
| Q2 2026 | 2025-10-24 | $42.49B | $1.16B | +2.81% |
| Q1 2026 | 2025-07-25 | $42.84B | $1.25B | +3.01% |
| Q4 2025 | 2025-04-25 | $43.42B | $3.86B | +9.76% |
| Q3 2025 | 2025-01-24 | $40.36B | $1.52B | +3.91% |
| Q2 2025 | 2024-10-25 | $41.33B | $2.89B | +7.51% |
| Q1 2025 | 2024-07-26 | $41.59B | $2.18B | +5.53% |
| Q4 2024 | 2024-04-26 | $39.56B | $278.0M | +0.71% |
| Q3 2024 | 2024-01-26 | $38.84B | −$3.68B | −8.65% |
| Q2 2024 | 2023-10-27 | $38.44B | −$2.74B | −6.66% |
| Q1 2024 | 2023-07-28 | $39.41B | $2.34B | +6.31% |
| Q4 2023 | 2023-04-28 | $39.28B | $1.02B | +2.67% |
| Q3 2023 | 2023-01-27 | $42.52B | $3.42B | +8.76% |
| Q2 2023 | 2022-10-28 | $41.18B | $1.59B | +4.01% |
| Q1 2023 | 2022-07-29 | $37.07B | −$3.07B | −7.64% |
| Q4 2022 | 2022-04-29 | $38.26B | −$3.22B | −7.77% |
| Q3 2022 | 2022-01-28 | $39.09B | −$7.25B | −15.65% |
| Q2 2022 | 2021-10-29 | $39.60B | −$5.97B | −13.11% |
| Q1 2022 | 2021-07-30 | $40.14B | −$3.33B | −7.65% |
| Q4 2021 | 2021-04-30 | $41.48B | $1.66B | +4.18% |
| Q3 2021 | 2021-01-29 | $46.34B | $5.47B | +13.39% |
| Q2 2021 | 2020-10-30 | $45.57B | $5.24B | +12.98% |
| Q1 2021 | 2020-07-31 | $43.46B | $2.69B | +6.60% |
| Q4 2020 | 2020-04-24 | $39.82B | $335.0M | +0.85% |
| Q3 2020 | 2020-01-24 | $40.87B | $2.08B | +5.36% |
| Q2 2020 | 2019-10-25 | $40.33B | $1.90B | +4.94% |
| Q1 2020 | 2019-07-26 | $40.77B | $1.38B | +3.50% |
| Q4 2019 | 2019-04-26 | $39.48B | −$1.09B | −2.68% |
| Q3 2019 | 2019-01-25 | $38.79B | −$6.67B | −14.67% |
| Q2 2019 | 2018-10-26 | $38.44B | −$4.44B | −10.36% |
| Q1 2019 | 2018-07-27 | $39.39B | −$10.07B | −20.36% |
| Q4 2018 | 2018-04-27 | $40.57B | −$8.96B | −18.08% |
| Q3 2018 | 2018-01-26 | $45.46B | −$2.63B | −5.46% |
| Q2 2018 | 2017-10-27 | $42.88B | −$5.23B | −10.88% |
| Q1 2018 | 2017-07-28 | $49.46B | $1.75B | +3.68% |
| Q4 2017 | 2017-04-28 | $49.53B | $1.95B | +4.09% |
| Q3 2017 | 2017-01-27 | $48.09B | −$3.81B | −7.33% |
| Q2 2017 | 2016-10-28 | $48.11B | −$4.56B | −8.66% |
| Q1 2017 | 2016-07-29 | $47.71B | −$4.11B | −7.93% |
| Q4 2016 | 2016-04-29 | $47.58B | −$5.87B | −10.99% |
| Q3 2016 | 2016-01-29 | $51.89B | $51.85B | +140143.24% |
| Q2 2016 | 2015-10-30 | $52.68B | — | — |
| Q1 2016 | 2015-07-31 | $51.82B | — | — |
| Q4 2015 | 2015-04-24 | $53.45B | $34.95B | +188.95% |
| Q3 2015 | 2015-01-23 | $37.0M | — | — |
| Q4 2014 | 2014-04-25 | $18.50B | — | — |
Medtronic total liabilities trends
Over the last five fiscal years, Medtronic's total liabilities increased from $41.48B to $42.96B, a change of $1.48B. The latest reported quarter, Q1 2027, shows $42.46B.
About the metric
What total liabilities mean
Total liabilities are all obligations reported on a company’s balance sheet, including debt, accounts payable, accrued expenses, deferred revenue, lease liabilities, and other current and long-term obligations.
Calculation and source
SEC-reported and calculated total liabilities
TickerStat uses total liabilities reported in company SEC filings when available. Otherwise, it calculates total liabilities as aligned total assets minus total equity for the same balance-sheet date. Total liabilities should not be confused with interest-bearing debt. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Medtronic source filings ↗Community posts
Medtronic begins European clinical use of its Stealth AXiS surgical system
Medtronic ($MDT) announced the first European procedures using its Stealth AXiS surgical system, with more than 23 procedures performed across seven sites in Germany, the UK, Italy and Spain. The initial experience includes spinal surgery. ...